Business · 07/10/1999Updated: 10/17/2026 · 1 min read
FDA Announces Approval of IND Regulations Under Paperwork Reduction Act
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to Investigational New Drug (IND) Regulations, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →